Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|July 9, 2002
Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftmentMickey B C Koh, H Grant Prentice, Marguerite Corbo, et al.
International Journal of Cancer|February 22, 2002
In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: a potential role in neuroblastoma therapyBryone J Kuss, Margherita Corbo, Wen Min Lau, et al.
Genes, Chromosomes & Cancer|January 27, 2005
Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemiaRebecca L Auer, Jane Starczynski, Suzanne McElwaine, et al.
Leukemia Research|December 6, 2001
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanismDeborah E Banker, John J Cooper, Dean A Fennell, et al.
Oncogene|January 25, 2003
Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemiaWei-Neng Fu, Francesco Bertoni, Stephen M Kelsey, et al.
The Journal of Experimental Biology|May 6, 2008
Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathwaysLayla J M Kily, Yuka C M Cowe, Osman Hussain, et al.
Blood|June 26, 2004
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Lancet (London, England)|May 16, 2003
Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorderJürgen Groet, Suzanne McElwaine, Monica Spinelli, et al.
British Journal of Haematology|November 23, 2006
Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemiaRebecca L Auer, Guillaume Dighiero, Lynn R Goldin, et al.
British Journal of Haematology|June 8, 2004
Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating markerSuzanne McElwaine, Claire Mulligan, Jürgen Groet, et al.
Pageof 3